首页> 美国卫生研究院文献>Frontiers in Medicine >Antigen-Specific Immunoadsorption With the Glycosorb® ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation

【2h】

Antigen-Specific Immunoadsorption With the Glycosorb® ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation

机译：抗原特异性免疫吸附与甘草株ABO免疫电容系统作为纯红细胞APLASIA的新型治疗方式术后主要和双向的ABO-不相容的同种异体造血干细胞移植

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Frontiers in Medicine
作者
Ammon Handisurya; Nina Worel; Werner Rabitsch; Marija Bojic; Sahra Pajenda; Roman Reindl-Schwaighofer; Wolfgang Winnicki; Andreas Vychytil; Hanna A. Knaus; Rainer Oberbauer; Kurt Derfler; Philipp Wohlfarth;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 8
原文格式 PDF
正文语种
中图分类情报学;
关键词

机译：纯红色血细胞Allasia（PRCA）;免疫吸附;造血干细胞移植;Isohemagglutinins;Glycosorb®;

相似文献

外文文献
专利

1. Antigen-Specific Immunoadsorption With the Glycosorb? ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation [J] . Ammon Handisurya, Rainer Oberbauer, Kurt Derfler, Frontiers in Medicine . 2020,第a期

机译：抗原特异性免疫吸附糖血管藻含量β？ ABO免疫吸附系统作为纯红细胞Allasia的新型治疗方式，术后双向和双向不相容的同种异体造血干细胞移植
2. Antigen-Specific Immunoadsorption With the Glycosorb® ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation [J] . Handisurya Ammon, Worel Nina, Rabitsch Werner, Frontiers in Medicine . 2020,第2期

机译：抗原特异性免疫吸附与甘草株ABO免疫电容系统，作为纯红细胞APLASIA的新型治疗方式，术后主要和双向的ABO-不相容的同种异体造血干细胞移植
3. Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb((R)) immunoadsorption. [J] . Rabitsch W, Knobl P, Prinz E, Bone marrow transplantation . 2003,第10期

机译：主要的ABO不相容异基因造血干细胞移植后，红细胞发育不良：通过Ig-Therasorb（R）免疫吸附去除持久的异血凝素。
4. Circulating Tumor DNA Predicts Post-Allogeneic Hematopoietic Stem Cell Transplantation in AML and MDS [C] . Sousuke Nakamura International Molecular Medicine Tri-Conference. . 2019

机译：循环肿瘤DNA预测AML和MDS中的同种异体造血干细胞移植
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. Pulsed-high-dose dexamethasone as a treatment for pure red cell aplasia following ABO-incompatible allogeneic stem cell transplantation [O] . X. Yang, M. Levis -1

机译：脉冲大剂量地塞米松治疗不兼容ABO的异基因干细胞移植后的纯红细胞发育不良
7. Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb® immunoadsorption [O] . W Rabitsch, P Knöbl, E Prinz, 2003

机译：延长红细胞Alvasia在主要的Abo-Numpatibal造血干细胞移植后：除去持续的Isohemag凝集蛋白，用IG-Therasorb®Immunoadallinal

Antigen-Specific Immunoadsorption With the Glycosorb® ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation

著录项

相似文献

相关主题

期刊订阅